NDC 63323-669-01 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-669
- Requested NDC
- 63323-669-01
- Package NDCs from labels
- 63323-669-01, 63323-669-10
- Manufacturer
- Fresenius Kabi USA, LLC | HP Halden Pharma AS
- Effective date
- 2024-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Fresenius Kabi USA, LLC | HP Halden Pharma AS | Fresenius Kabi USA, LLC | HP Halden Pharma AS | 2024-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-669-01 | Potassium Chloride | 1000 mL in 1 BAG | INJECTION, SOLUTION | 1000 | 4 | |
| 63323-669-10 | Potassium Chloride | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-669-01 | ML - Milliliter | 63323-669 | df69b3e2-d314-4b8a-b889-22a29d258378 | 1 | 2022-11-07 |
| 63323-669-10 | ML - Milliliter | 63323-669 | a4d22102-39bb-45a1-afb0-29254d692766 | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals of New York LLC | cd56e147-92d6-46ce-ae00-63fac08d49b5 | 2026-03-03 | Warnings, Adverse reactions | 660YQ98I10 |
| BM BIO28 (General Tonic) | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | BM Private Limited | 38d2cff0-3550-b119-e063-6394a90a31cb | 2026-02-23 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 2d67fc67-c99f-4df2-a1e7-4d369cce12c2 | 2026-02-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Fuligo | CIMICIFUGA, DROSERA, FORMICA RUFA, FULIGO, INULA HEL., KALI MUR, LAPIS ALBUS, SILICEA | BM Private Limited | 3b27225f-4587-d915-e063-6294a90a7225 | 2026-02-12 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Major Pharmaceuticals | 33ad1eb2-1f05-461c-b01d-82dee4231556 | 2026-02-11 | Warnings, Adverse reactions | 660YQ98I10 |
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | LX22YL083G |
| POKONZA potassium chloride | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 2d938cbf-27aa-4f9c-a582-5564d3b72465 | 2026-01-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | ProPharma Distribution | 48c0ee87-f722-1a71-e063-6394a90a72d1 | 2026-01-19 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 755a4a08-04ff-d7d1-a6fc-b8aeff3ae2c6 | 2026-01-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | B. Braun Medical Inc. | 7dff29d9-522d-40eb-a9d9-42377912d640 | 2026-01-14 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | Advagen Pharma Limited | d528c0c1-b81f-4f7a-8518-e6911b23c3eb | 2026-01-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Lung Drainage | ANTIMONIUM ARSENICICUM, BRYONIA (ALBA), CAMPHORA, CARBO VEGETABILIS, CHELIDONIUM MAJUS, CHININUM MURIATICUM, CUPRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HAEMOPHILUS INFLUENZAE B, IPECACUANHA, KALI MURIATICUM, LOBELIA PURPURESCENS, LUNG (SUIS), MYCOPLASMA PNEUMONIAE, MYCOPLASMA PNEUMONIAE DNA, OXYGENIUM, PHOSPHORUS, PNEUMOCOCCINUM, SENEGA OFFICINALIS, STANNUM METALLICUM, VERATRUM VIRIDE | Deseret Biologicals, Inc. | fd109172-46c3-444e-9fa0-124f785c3fb5 | 2026-01-09 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvPAK | f32df7c0-33eb-e6d6-e053-2a95a90a2e8d | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Baxter Healthcare Corporation | 092ddee4-572d-4771-8d95-880cea01097e | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Flex Drops 2024 | FLEX DROPS | Professional Complementary Health Formulas | e857670f-de84-494e-9e81-80144792d1fa | 2026-01-08 | Warnings | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.